GLP-1 Receptor Agonists
6 drugs in this class, prescribed by 153,644 Medicare Part D providers.
Data: CMS Medicare Part D, 2023 (most current available) · Updated March 2026
$8.51B
Total Cost
6,297,872
Claims
6
Drugs
$1,352
Avg Cost/Claim
Key Insights
- Most expensive per prescription: Xultophy 100-3.6 at $1,607/claim
- Most prescribed: Ozempic with 3,193,643 claims
- This class represents 3.1% of total Medicare Part D spending
All GLP-1 Receptor Agonists Drugs
| Drug | Cost | Claims |
|---|---|---|
| Semaglutide | $4.30B | 3,193,643 |
| Dulaglutide | $2.99B | 2,175,100 |
| Tirzepatide | $877.9M | 680,457 |
| Liraglutide | $273.0M | 189,358 |
| Exenatide Microspheres | $56.6M | 48,670 |
| Insulin Degludec/Liraglutide | $17.1M | 10,644 |